| Range: | 0.31-4.24 | Vol Avg: | 242042 | Last Div: | 0 | Changes: | -0.08 |
| Beta: | -0.41 | Cap: | 0.03B | Currency: | USD | Exchange: | NYSE |
| Sector: | Healthcare | IPO: | Mon Mar 29 2021 | Empoloyees: | 501 | ||
| CUSIP: | 02008G102 | CIK: | 0001964979 | ISIN: | US02008G1022 | Country: | US |
| CEO: | Dr. Shantanu K. Gaur M.D. | Website: | https://www.allurion.com | ||||
ALUR 0.39 Stock Price Allurion Technologies Inc.
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.
Stock Details
Positive 0.23
Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALU...
businesswire.com·Mon Nov 25 2024
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow